1/3

FIEO Registered Export Ready

Montelukast & DoxofyllineTablets

Name: Montelukast & DoxofyllineTablets
Brand: indiglobal exports
SKU: 8520343
Availability: InStoreOnly

Sold by indiglobal exports · Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

On request

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for indiglobal exports.

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Panchkula Dispatch on request FIEO member

indiglobal exports

Service Provider , Professional Services, Exporter, Wholesaler · Panchkula, Haryana, India

We are a distinguished merchant trading and export company, specializing in the international supply of premium-quality products across various sectors. Our portfolio includes pharmaceuticals, marketed under a neutral code, as well as millets, mango pulp, compounded animal and livestock feed, and orthopaedic appliances. We take great pride in our meticulous product selection and procurement processes, consistently adhering to the highest standards of quality assurance to ensure the delivery of superior goods to our clients.

Registered address: Chandigarh, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Medical Equipment & Supplies.

View profile All products

Established

2024

Employees

1–10

GST

06EOGPS3248L1ZF

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Apr 2024

Turnover

2500001 - 10000000.

Incorporation Type

On request

Verified Seller IEC Certificate GST Certificate UDYAM Registration Certificate

Product details

What are the specifications of this product?

Overview

Montelukast & Doxofylline Tablets is a pharmaceutical product indicated for respiratory treatment. This formulation is manufactured with export-quality standards to ensure therapeutic efficacy, consistent dosage, and compliance with international healthcare regulations. Features: Used in the management of respiratory conditions Precise dosage form and active pharmaceutical ingredients Suitable for international pharmaceutical markets Manufactured in GMP-compliant facilities Reliable therapeutic performance Attributes: Category: Respiratory Formulation: Tablet Packaging: Export-grade blister or strip packs Shelf Life: As per regulatory standards Manufacturer: IndiGlobal Exports

Product Description

Product Overview

Montelukast & Doxofylline Tablets is developed for the effective management of respiratory conditions, offering reliable performance backed by stringent pharmaceutical standards. Each batch is carefully produced and tested to ensure consistency, safety, and compliance with global export norms.

Therapeutic Use & Application

This formulation supports the clinical treatment and ongoing care of patients with respiratory indications. Commonly prescribed in hospital and retail pharmacy settings, it ensures measurable therapeutic benefit.

Formulation & Packaging

Crafted in state-of-the-art facilities, this tablet formulation ensures accuracy in dosing and ease of administration. It is typically available in secure blister or strip packs suitable for bulk export or institutional supply.

Quality & Compliance

The product is manufactured in facilities adhering to WHO-GMP standards and complies with pharmacopoeial quality benchmarks (IP/USP). Ideal for regulated and semi-regulated markets seeking quality-assured medications.

Description provided by indiglobal exports.

Specifications

Category	Respiratory
Formulation	Tablet
Active Pharmacological Agents	Montelukast (anti-leukotriene), Doxofylline (bronchodilator)
Packaging Type	Blister or strip packs designed for export
Compliance	WHO-GMP, IP and USP standards
Intended Use	Clinical and ongoing respiratory condition management
Storage Requirements	Store in a cool, dry place away from direct sunlight
Batch Consistency	Stringent quality control to ensure uniform dosage and efficacy

Use cases

Category	Pharmaceuticals > Respiratory Medicines > Combination Tablets
Primary application	Wholesale, distribution, and international sourcing
Brand	indiglobal exports
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Montelukast & DoxofyllineTablets. Answers compiled from verified sellers' commercial terms and platform data.

Q: What makes Montelukast & Doxofylline tablets suitable for international pharmaceutical markets?

A: These tablets are manufactured in WHO-GMP certified facilities with adherence to IP and USP pharmacopoeial standards, and packaged in export-grade blister or strip packs that meet global regulatory requirements.

Q: How does the combination of Montelukast and Doxofylline improve respiratory treatment efficacy?

A: Montelukast reduces airway inflammation and bronchoconstriction by blocking leukotriene receptors, while Doxofylline serves as a bronchodilator that relaxes airway muscles, together providing complementary effects for improved respiratory relief.

Q: Can these tablets be used for both asthma and COPD patients?

A: Yes, the combination formulation is indicated for management of various respiratory conditions including asthma and COPD, offering therapeutic benefit for both types of patients.

Q: What packaging options are available for bulk pharmaceutical buyers?

A: Montelukast & Doxofylline tablets are supplied in export-grade blister or strip packs designed for bulk export and institutional supply, ensuring product stability during transit.

Q: What quality control measures ensure consistency of this tablet formulation?

A: The manufacturer enforces stringent batch testing and quality control protocols to maintain uniform dosage accuracy, safety, and therapeutic efficacy across production runs.

Question not answered? Ask sellers directly — typical response within 4 hours.